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Abstract
Background: The aim of this study was to examine the symptomatic dimensions of depression in
a large sample of patients with major depressive disorder (MDD) in the primary care (PC) setting
by means of a factor analysis of the Zung self-rating depression scale (ZSDS).
Methods: A factor analysis was performed, based on the polychoric correlations matrix, between
ZSDS items using promax oblique rotation in 1049 PC patients with a diagnosis of MDD (DSM-IV).
Results: A clinical interpretable four-factor solution consisting of a core depressive factor (I); a
cognitive factor (II); an anxiety factor (III) and a somatic factor (IV) was extracted. These factors
accounted for 36.9% of the variance on the ZSDS. The 4-factor structure was validated and high
coefficients of congruence were obtained (0.98, 0.95, 0.92 and 0.87 for factors I, II, III and IV,
respectively). The model seemed to fit the data well with fit indexes within recommended ranges
(GFI = 0.9330, AGFI = 0.9112 and RMR = 0.0843).
Conclusion: Our findings suggest that depressive symptoms in patients with MDD in the PC
setting cluster into four dimensions: core depressive, cognitive, anxiety and somatic, by means of a
factor analysis of the ZSDS. Further research is needed to identify possible diagnostic, therapeutic
or prognostic implications of the different depressive symptomatic profiles.
Background
Depression can be manifested as a combination of a wide
variety of symptoms: loss of interest, depressed mood,
psychic anxiety, somatic anxiety, altered appetite, altered
sleep, painful symptoms, etc. [1]. In the primary care (PC)
setting, approximately two thirds of patients with depres-
sion report somatic symptoms solely as the reason for
consultation [1]. Indeed, depression is mostly difficult to
recognize in such patients being the major reason for
underdiagnosis and undertreatment of depression in PC
[1-4].
Traditionally, the heterogeneous symptoms of depression
have been grouped into different symptomatic dimen-
sions according to their clinical significance but there is
no consensus on how this is best done [1,5]. Hence,
depressive symptoms have been grouped into psycholog-
ical and somatic [1]; into affective, cognitive, vegetative,
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behavioural, physical and impulsive-control [6,7]; or into
affective, somatic and cognitive symptoms [8], etc. How-
ever, from a clinical perspective, the grouping of depres-
sive symptoms into symptomatic dimensions is purely
intuitive and lacks empirical evidence. There is evidence
that patients with different depressive symptom profiles
are likely to have different prognosis and therefore might
require a different therapeutic approach [9]. Furthermore,
depressive symptoms have shown to differentially predict
survival in patients with coronary artery disease [10].
Therefore, identifying the symptomatic dimensions of
depression is relevant because of their diagnostic and ther-
apeutic implications [3,4].
There are few studies that identify or empirically group
depressive symptoms into symptomatic dimensions.
Some have analysed the factor structure of commonly
used diagnostic instruments for depression, such as the
Zung self-rating depression scale (ZSDS) or the Hamilton
depression rating scale (HAMD-D), to examine the degree
to which the emerged factors represent symptoms clusters
and to assess whether the obtained factor structures are or
not equivalent across subgroups (age, gender, diagnosis,
etc.) [9].
In particular, the factor structure of the ZSDS has been
studied in different populations, such as healthy subjects
over the age of 65 [11], pregnant women [12], patients
with heart disease [10], cancer [13,14] or chronic muscle
pain [15], students [16,17], workers [18,19] etc., obtain-
ing different factor structures. To date, and to our knowl-
edge there are no studies examining the factor structure of
the ZSDS in patients with depression in the PC setting.
Because of the underdiagnosis and undertreatment of
depression in PC [2-4,20,21] as well as the possible future
implications of different symptomatic profiles in the
prognosis of depression, we believe that studying the
symptomatic dimensions in this population is of great
interest. We hypothesized that depressive symptoms in
patients with MDD would be empirically grouped into
symptomatic dimensions and that this grouping would be
of clinical significance. For this purpose, we examined the
factor structure and the composition of the resulted fac-
tors in a large sample of patients with MDD in PC by
means of a factor analysis of the ZSDS.
Methods
The factor analysis presented in the current manuscript is
a post-hoc analysis of the data reported in a large cross-
sectional epidemiological study conducted on 1150
patients diagnosed with MDD, in accordance with the
Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition  (DSM-IV) criteria [22]. The study was reviewed
and approved by the ethical review committee of Puerta
de Hierro Hospital in Madrid.
Patients were selected from seventy-nine PC sites widely
distributed across Spain. Subjects seeking consultation for
whatever reason between April and July 2004 were
selected using a systematic procedure based on appoint-
ment logs. Other inclusion criteria included being at least
18 years of age and not having any condition that would
impede understanding of the study or the informed con-
sent. A signed authorization for the collection and use of
clinical data in accordance with standing regulations
regarding personal data protection was obtained from all
subjects prior to enrolment. Screening for depressive
symptoms was performed at a cut-off point of ≥ 3 positive
responses on the 9-item scale of depression of the Spanish
version of the Goldberg Anxiety and Depression Scale
(GADS) [23]. According to available data [24] this cut-off
yields sensitivity of 0.74 and specificity of 0.93. The con-
firmation of MDD diagnosis as per the DSM-IV criteria
was evaluated by means of the Mini International Neuropsy-
chiatric Interview (MINI) [25]. All participating physicians
attended a one-day training session prior to study com-
mencement to establish uniform criteria as to the use of
the assessment instruments and data collection.
The severity of depression was assessed by the patients
using the ZSDS and by physicians using the Clinical Glo-
bal Impression of Severity (CGI-S). The Zung self-rating
depression scale [26] is a self-reported 20-item measure of
the symptoms of depression. Items responses are ranked
from 1 to 4, with higher scores corresponding to more fre-
quent symptoms. Therefore, for each item, patients have
to score according to whether the item has occurred 1 = A
little of the time/very rarely/rarely; 2 = Once in a while/
some of the time/occasionally; 3 = Good part of the time/
very often/often; 4 = Most of the time/always/almost
always. Ten items are worded positively and the other 10
are worded negatively. Total scores on the ZSDS do not
correspond with a clinical diagnosis of depression but
rather indicate the level of depressive symptoms that may
be of clinical relevance. It has been established as a valid,
reliable instrument in several studies in order to measure
depressive symptoms [27-29]. The CGI-S scale is a 7-cate-
gory scale in which the investigator scores the severity of a
patient's mental disorder. Thus 1 = "normal, not
depressed;" 2 = "on the border of depression;" 3 = mildly
depressed;" 4 = "moderately depressed;" 5 = "notably
depressed;" 6 = "severely depressed," 7 = "extremely
depressed."
Exploratory Factor Analysis of the ZSDS
An exploratory factor analysis on the ZSDS scores was
used to extract the factor solution. The factor analysis was
performed, based on the polychoric correlations matrixBMC Psychiatry 2008, 8:4 http://www.biomedcentral.com/1471-244X/8/4
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between ZSDS items by means of the unweighted least
squares method, since the normality supposition was not
met [30], and using promax oblique rotation [31]. After
rotation items with a loading of at least 0.25 were consid-
ered to load significantly onto a particular factor.
The sample was divided into two sub-samples of 75% and
25%. The first sample was used to perform an exploratory
factor analysis (exploratory phase) and the second was
used to validate the results (validation phase) and to per-
form a confirmatory factor analysis by means of the
unweighted least squares method. We used several
indexes such as the Goodness of Fit Index (GFI), which
should be greater than 0.90 for good-fitting models, GFI
Adjusted for Degrees of Freedom (AGFI), with a value of
0.90 as the cut-off value [32] and Root Mean Square
Residual (RMR), the larger the RMR value the less is the fit
between the model and the data [30].
Finally, subgroups were analysed by gender, age (≤ 65
years vs. > 65 years), place of residence (rural vs. semi
rural vs. urban) and severity of depression groups, using
the Clinical Global Impression Severity Scale (CGI-S).
CGI values were grouped as follows: mild-moderate:
"mildly depressed" (3), "moderately depressed" (4) and
"notably depressed" (5); Severe: "severely depressed" (6)
and "extremely depressed" (7). To compare these groups,
mean estimates were made of each factor, by adding the
mean scores of all patients in each factor extracted from
the factor model in each group. A variance analysis was
performed to detect any differences.
And finally, a descriptive examination of the 20-item
ZSDS was performed at a quantitative level, calculating
sample means and standard deviations, and also at a cat-
egorical level, providing percentages for each response.
Results
Descriptive characteristics
Table 1 shows the demographic and clinical characteris-
tics of the patients. It should be noted that the sample was
predominantly female (75.2%), 54% of patients were not
currently diagnosed with depression by their doctor, and
remarkably only 31% of patients were receiving antide-
pressant treatment.
Prevalence of depressive symptoms according to the ZSDS
A total of 1049 (91.2%) patients completed the question-
naire. The characteristics of depressive symptoms accord-
ing to the ZSDS are detailed in Figure 1. The highest mean
scores of the ZSDS were observed in the following items:
psychomotor retardation (mean = 3.29; CI 95%:
3.24–3.34), confusion (mean = 3.28; CI 95%: 3.22–3.33),
indecisiveness (mean = 3.13; CI 95%: 3.08–3.19), empti-
ness (mean = 3.02; CI 95% 2.96–3.07) and depressed
affect (mean = 3.01; CI 95% 2.96–3.06). Of note, the
most frequent symptoms (psychomotor retardation and
confusion) were reported by 50% of patients as present
most of the time/always/almost always (Figure 1).
The lowest mean scores of the ZSDS were observed in
items: suicidal rumiation (mean = 1.63, CI 95%:
1.57–1.68), weight loss (mean = 1.73, CI 95%:
1.67–1.79) and constipation (mean = 1.99, CI 95%:
1.92–2.05). Of these, suicidal rumiation and constipa-
tion, the least frequent symptoms were mostly reported as
sporadic (a little of the time/very rarely/rarely) (Figure 1).
Exploratory Factor Analysis of the ZSDS
In the exploratory phase (n = 787), factor extraction
resulted in four factors with a significant eigenvalue of at
least 1.0 which explained 36.9% of total variance on the
ZSDS item intercorrelations. Each factor was composed of
3 to 8 items, with no items loading in more than one fac-
tor. After rotation of the four-factor solution, items were
considered to load on a factor if the rotated factor loading
was at least 0.25. It was then assessed by the research cli-
Table 1: Demographic and clinical characteristics of patients (n = 
1150)
Demographic and clinical 
characteristics
Patients with MDD
Nn%
Gender
Women 1138 856 75.2
Men 1138 282 24.8
Place of residence
Urban 1142 537 47.0
Semi-urban 1142 384 33.6
Rural 1142 221 19.4
Current diagnosis of depression for this 
episode
1097 504 45.9
Severity of depression (ZSDS)
None 1049 42 4.0
Mild 1049 185 17.6
Moderate 1049 355 33.8
Severe/extreme 1049 467 44.5
Current medication
Analgesics/anti-inflammatories 1150 616 53.6
Benzodiazepines 1149 518 45.1
Antidepressants 1150 356 31.0
Antipsychotics 1150 23 2.0
NM e a n S D
Age (in years) 1112 55.0 15.4
CGI-S 1121 4.1 1.2BMC Psychiatry 2008, 8:4 http://www.biomedcentral.com/1471-244X/8/4
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nician whether the factor solution obtained could have a
clinical interpretation (Table 2).
The first factor (factor I) accounting for 23.8% of the scale
variance, was composed of 8 items: depressed affect (item
1), crying spells (item 3), decreased libido (item 6), hope-
lessness (item 14), personal devaluation (item 17), emp-
tiness (item 18), suicidal rumiation (item 19) and
dissatisfaction (item 20). The second factor (factor II) was
composed of 4 items: confusion (item 11), psychomotor
retardation (item 12), indecisiveness (item 16) and
fatigue (item 10). This factor accounted for 5.8% of vari-
ance. The third factor (factor III), which accounted for
3.7% of variance, consisted of 3 items: sleep disturbances
(item 4), psychomotor agitation (item 13) and irritability
(item 15). Finally, factor IV, accounting for 3.5% of vari-
ance, consisted of 3 items: decreased appetite (item 5),
weight loss (item 7) and tachycardia (item 9) (Figure 2).
According to the polychoric correlations matrix, all items
except diurnal variation (item 2) and constipation (item
8), presented high intercorrelations with items within the
same factor (Table 2). The items relating to diurnal varia-
tion and constipation were eliminated from the factor
analysis because of their low correlation with the other
items.
The four-factor solution was validated and an identical
factor solution was obtained with high congruence coeffi-
cients (CC) for each factor: 0.98 (factor I), 0.95 (factor II),
0.92 (factor III) and 0.87 (factor IV) (Figure 2). After this,
a second model was run to obtain a 3-factor solution. The
resulted 3-factor solution was less optimal since it
accounted for less of the total variance (33.3%), presented
items loading in more than one factor and items with very
low factor weights (< 0.25), and also it was much less clin-
ically meaningful than the 4-factor structure.
Confirmatory Factor Analysis
The obtained indexes for the 4-factor model were GFI =
0.9330, AGFI = 0.9112 and RMR = 0.0843, and for the 3-
factor model were GFI = 0.9164, AGFI = 0.8917 and RMR
= 0.0942. Examination of the fit indexes indicated that
both models came close to fitting the data however the 4-
factor model had better goodness-of-fit coefficients.
Besides the 3-factor model did not achieve an acceptable
AGFI value whereas the 4-factor model did.
Given the large sample size, the stability of the final four
factor solution was determined by repeating exploratory
factor analysis of ZSDS items separately on females and
males and on patients aged ≤ 65 years and > 65 years,
respectively. This analysis showed an identical factor solu-
Table 2: Pattern of factors after rotation. Values for items with 
greater weight and greater intercorrelation are highlighted in 
bold
Items Factor I Factor II Factor III Factor IV
18: Emptiness 0.81020 0.02694 -0.07882 -0.05805
14: Hopelessness 0.71806 -0.01248 0.00358 0.01279
17: Personal 
devaluation
0.66729 0.06068 -0.05545 -0.16968
19: Suicidal 
rumiation
0.59081 -0.05977 0.14953 0.05850
20: Dissatisfaction 0.56170 0.21835 -0.12945 0.11518
1: Depressed affect 0.48840 0.03523 0.27387 0.06180
6: Decreased libido 0.39334 0.11583 -0.11821 0.24162
12: Psychomotor 
retardation
-0.02329 0.76309 -0.01425 0.04242
11: Confusion -0.00711 0.62654 0.10019 -0.00484
16: Indecisiveness 0.27074 0.35343 0.03434 -0.01957
10: Fatigue 0.12667 0.27508 0.18488 0.06714
13: Psychomotor 
agitation
-0.06231 0.07960 0.53666 0.01544
15: Irritability 0.01450 0.10047 0.52265 0.08437
3: Crying spells 0.38120 0.00120 0.33934 0.08437
4: Sleep disturbances 0.03951 0.01288 0.31263 0.20566
5: Decreased 
appetite
-0.00035 0.12560 -0.13281 0.55308
7: Weight loss -0.04474 -0.02156 0.05212 0.53798
9: Tachycardia 0.13362 -0.07156 0.25808 0.26486 Characteristics of depressive symptoms according to the  Zung Self-Rating Depression Scale (n = 1049) Figure 1
Characteristics of depressive symptoms according to 
the Zung Self-Rating Depression Scale (n = 1049). The 
highest score in a single item of the ZSDS is 4 (i.e. most of 
the time/always/almost always) and the lowest score is 1 (i.e. 
a little of the time/very rarely/rarely)
 
 
Percentage of patients 
Mean score (CI 95%) 
3.29 (3.24-3.34) 
3.28 (3.22-3.33) 
3.13 (3.08-3.19) 
3.02 (2.96-3.07) 
3.01 (2.96-3.06) 
2.99 (2.93-3.06) 
2.99 (2.92-3.06) 
2.96 (2.90-3.02) 
2.92 (2.87-2.98) 
2.87 (2.82-2.93) 
2.82 (2.76-2.88) 
2.72 (2.66-2.79) 
2.71 (2.65-2.77) 
2.68 (2.62-2.73) 
2.62 (2.56-2.68) 
2.54 (2.48-2.60) 
2.23 (2.17-2.29) 
1.99 (1.92-2.05) 
1.73 (1.67-1.79) 
1.63 (1.57-1.79) 
0%  20%  40% 60% 80% 100% 
Suicidal rumiation 
Weight loss 
Constipation 
Tachycardia 
Psychomotor agitation 
Irritability 
Crying spells 
Personal devaluation 
Decreased appetite
Dissatisfaction 
Fatigue 
Hopelessness 
Sleep disturbance
Decreased libido 
Diurnal variation 
Depressed affect 
Emptiness 
Indecisiveness 
Confusion 
Psychomotor retardation 
Once in a while / some of the time / occasionally (Score 2)
Good part of the time / very often / often (Score 3 )
Most of the time / always / almost always (Score 4)
A little of the time / very rarely / rarely (Score 1)BMC Psychiatry 2008, 8:4 http://www.biomedcentral.com/1471-244X/8/4
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tion in females (mean CC: 0.98); in males (mean CC:
0.94) and in patients aged ≤ 65 years (mean CC: 0.99).
However, for patients >65 years, very low CCs were
obtained for factor IV.
Comparison of factor scores by demographic and clinical 
characteristics
A post-hoc analysis revealed that females had significantly
higher scores in factor III (sleep disturbances, psychomo-
tor agitation and irritability) than males (p < 0.001). The
same comparison between age groups showed that
patients over the age of 65 presented significantly higher
scores in factor I (depressed affect, crying spells, decreased
libido, hopelessness, personal devaluation, emptiness,
suicidal rumination and dissatisfaction) and IV
(decreased appetite, weight loss and tachycardia) than
those under 65 years (p < 0.001 and p = 0.0002, respec-
tively). Finally, when comparing factor I scores in patients
from rural vs. urban settings significantly higher factor
scores were observed in patients from a rural or semi-rural
setting (p = 0.0005). There were no other significant dif-
ferences between factor scores and gender, age, place of
residence and severity of depression.
Discussion
The four factors extracted from the factor analysis were
interpreted, according to the nature of the symptoms in
each factor, as:core depressive factor (Factor I), cognitive fac-
tor (Factor II), anxiety factor (Factor III) and somatic factor
(Factor IV).
The core depressive factor appears to primarily reflect emo-
tional or affective symptoms of depression, such as
depressed affect, suicidal rumiation, dissatisfaction and
personal devaluation. Other studies have identified a sim-
ilar factor but used different labels, "manifest depressed
mood" [13], "general depression" or "negative affect" being
depressed mood the core symptom in all of them [33].
Factor I has the greatest weight, accounting for 23.8% of
the ZSDS variance, which suggests that factor I symptoms
are more specific of depression and therefore more rele-
vant when diagnosing depression in PC patients. This fac-
tor includes two symptoms that are essential in order to
diagnose depression such as depressed mood and loss of
interest or ability to enjoy things as reflected in items 1: "I
feel down-hearted and blue," 14: "I feel hopeful about the
future" and 20: "I still enjoy the things I used to do." It
should be noted that the "decreased libido" item is
included in factor I. In other studies this item was also
Factor solution of the Zung Self-Rating Depression Scale Figure 2
Factor solution of the Zung Self-Rating Depression Scale.
 
Factors and items 
 
 CC 
Factor 
weights 
Factor I. “Core Depressive” 
Item 1: Depressed affect; I feel down-hearted and blue 
Item 3: Crying spells; I have crying spells or feel like it 
Item 6: Decreased libido; I still enjoy sex 
Item 14: Hopelessness; I feel hopeful about the future 
Item 17: Personal devaluation; I feel that I am useful and needed 
Item 18: Emptiness; My life is pretty full 
Item 19: Suicidal rumiation; I feel that others would be better off if I were 
dead 
Item 20: Dissatisfaction; I still enjoy the things I used to do 
0.98   
0.48 
0.38 
0.39 
0.71 
0.66 
0.81 
 
0.59 
0.56 
Factor II. “Cognitive” 
Item 10: Fatigue; I get tired for no reason 
Item 11: Confusion; My mind is as clear as it used to be 
Item 12: Psychomotor retardation; I find it as easy to do the things as  
I used to 
Item 16: Indecisiveness; I find it easy to make decisions 
0.95   
0.27 
0.62 
 
0.76 
0.35 
Factor III. “Anxiety” 
Item 4: Sleep disturbance; I have trouble sleeping at night 
Item 13: Psychomotor agitation; I am restless and I can’t keep still  
Item15: Irritability; I am more irritable than usual 
0.92   
0.31 
0.53 
0.52 
Factor IV. ”Somatic” 
Item 5: Decreased appetite; I eat as much as I used to 
Item 7: Weight loss; I notice that  I am losing weight 
Item 9: Tachycardia; My heart beats faster than usual 
0.87   
0.55 
0.53 
0.26 
None 
Item 2: Diurnal variation; Morning is when I feel the best 
Item 8: Constipation; I have trouble with constipation 
CC; Congruence coefficients BMC Psychiatry 2008, 8:4 http://www.biomedcentral.com/1471-244X/8/4
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associated with core depressive symptoms [6,11] possibly
due to the way in which this item is worded "I still enjoy
sex" that would reflect the loss of sexual drive.
Factor II appears to reflect symptoms related to difficulty
in concentrating/decision-making, confusion or loss of
mental clarity, and psychomotor retardation. These items
seem to reflect altered cognitive function possibly due to
decreased concentration and speed of response. Indeed,
this is why this factor has been interpreted as cognitive.
Sugawara M and colleagues found a similar grouping of
ZSDS items (confusion, psychomotor retardation and
indecisiveness) in a sample of women during pregnancy
and the post-partum period [12].
Interestingly, unlike other factor studies on the ZSDS [11-
16,18,19] we have found a factor (III) that groups items
associated with typical symptoms of anxiety disorders
(irritability, psychomotor agitation, restlessness, and
sleep disturbances) in particular generalised anxiety disor-
der [33]. For this reason factor III has been labelled as anx-
iety factor. Despite methodological differences, these
symptoms (irritability, psychomotor agitation and sleep
disturbances) were also grouped together in another study
conducted on a combined sample of PC attenders and
community residents [5]. It is possible that, unlike other
factor analyses of the ZSDS, we have identified an anxiety
dimension due to the fact that our sample comes from a
PC setting, with a predominance of females (75.2%). This
is consistent with previous reports showing that anxious
depression is more likely to be present amongst women
and in PC settings [34]. With regard to factor IV, inter-
preted as a somatic factor (decreased appetite, weight loss
and tachycardia), our findings are consistent with those
reported by other studies [10,13,17].
Collectivelly, these results indicate that the ZSDS provides
a factor structure of clinical relevance in this patient pop-
ulation. However, since the factor structure of this scale
has not been examined in PC patients with depression
before further studies are needed in order to confirm these
results. When interpreting this factor solution it is worth
noting that our sample is a PC population with a diagno-
sis of current MDD episode present only in less than half
of patients (45.9%) and only 31% of depressed patients
were taking antidepressant medication. This reflects the
underdiagnosis and undertreatment of MDD in PC
already addressed at length by other studies [35-38].
Previous factor analysis studies on ZSDS have proposed
four-, three- or two- factor models with differences in the
type and number of items loaded in each factor. This may
be due to the fact that those studies were conducted on
different sample populations. It is not surprising to find
diverse clusters of symptoms as the profile of depressive
symptoms also differs across miscellaneous populations
[9,39]. As previously mentioned similar studies need to be
conducted on patients with MDD in a PC setting in order
to confirm our results and to clarify whether or not there
is a characteristic profile of symptoms in patients with
depression in PC. It would be also interesting to assess the
possible diagnostic, therapeutic or prognostic implica-
tions of the different symptomatic profiles.
The notably high factor III scores in females indicate that
females with MDD in a PC setting are more likely to
present depression-related anxiety symptoms than males.
However no such differences emerged between gender
and factors I, II and IV. In this respect our data confirm
previous results reporting a higher prevalence of anxiety
symptoms in women than men [40,41]. When comparing
factor scores by age groups, we observed that patients over
the age of 65 with MDD in a PC setting tend to present
more core depressive and somatic symptoms than
patients aged 65 and under. These findings support data
obtained by other authors suggesting that elderly patients
with MDD are more commonly characterised by the man-
ifestation of somatic symptoms than younger patients
[42-44]. Finally, we did not find differences with regard to
gender or place of residence as expected [1,45], possibly
because few somatic items loaded in this factor.
Limitations
Although this study used a large sample of patients, the
results must be interpreted with caution. Considering that
the factor solution accounted for only 36.9% of variance
in the ZSDS, and that it was decided to exclude items 2
and 8 from the factor analysis because of their low corre-
lation, it would not be appropriate to extract 4 sub-scales
from these factors. Extracting four sub-scales would mean
that some of the original items, specifically items 9 (tach-
ycardia) and 10 (fatigue) would not be properly
accounted for. One limitation in our study is that fatigue
loads in the cognitive factor but with a low factor weight
and an ambiguous clinical interpretation therefore this
result should be interpreted with caution.
The obtained factor solutions in other studies accounted
for variances ranging from 32–33% [18,19] to 46%–48%
[10,13]. Similarly, the low percentages of variability
explained by the anxiety  (III) and somatic  (IV) factors,
3.7% and 3.5% respectively, may reflect limited stability
of those factors. However the stability of the final four fac-
tor solution was confirmed since an identical factor struc-
ture was extracted in females, males and patients aged ≤
65. Also there are studies reporting a somatic factor with
the same items loading to that factor as we have found.
The cross-sectional character of the study does not allow
the identification of the stability of the resulted factors.BMC Psychiatry 2008, 8:4 http://www.biomedcentral.com/1471-244X/8/4
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Further, the lack of a control population without depres-
sion makes impossible to draw comparisons with a non-
clinical population. Finally, when comparing factor scores
according to the demographic and clinical characteristics
of patients, we noted significant differences in sample size
impairing the statistical power of these analyses.
Conclusion
To our knowledge, this is the first study that identifies four
symptomatic factors of depression in a large sample of
patients with MDD in PC. Depressive symptoms in PC
patients cluster into core depressive, cognitive, anxiety and
somatic dimensions by means of a factor analysis of ZSDS.
However, since the factor structure of this scale has not
been previously examined in such population, further
investigation is needed in order to confirm these results.
Future studies could help to clarify whether there is a char-
acteristic profile of symptoms in patients with depression
in PC as well as any possible diagnostic, therapeutic or
prognostic implications of the different symptomatic pro-
files.
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